Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II ketotifen plus chemotherapy in sarcoma
2022-002311-39Phase 2Completed
- Sponsor
- University of Cyprus
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ketotifen in Bone and soft tissue sarcoma, sponsored by University of Cyprus. Primary endpoints: Primary efficacy endpoint and Tumor stiffness biomarker endpoint. Started Sep 2022; status: completed.
02
Drugs
ketotifen
03
Conditions
Bone and soft tissue sarcoma
Beyond the preview
Go deeper on 2022-002311-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002311-39.